Akebia Therapeutics
AKBA
#7392
Rank
โ‚น39.85 B
Marketcap
โ‚น150.18
Share price
1.84%
Change (1 day)
-7.82%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: โ‚น39.85 Billion

As of December 2025 Akebia Therapeutics has a market cap of โ‚น39.85 Billion. This makes Akebia Therapeutics the world's 7392th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น39.85 B9.19%
2024โ‚น36.49 B87.68%
2023โ‚น19.44 B121.4%
2022โ‚น8.78 B-70.16%
2021โ‚น29.43 B-0.56%
2020โ‚น29.59 B-46.03%
2019โ‚น54.83 B21.33%
2018โ‚น45.19 B0.71%
2017โ‚น44.88 B65.54%
2016โ‚น27.11 B2.98%
2015โ‚น26.32 B75.19%
2014โ‚น15.02 B

End of Day market cap according to different sources

On Dec 11th, 2025 the market cap of Akebia Therapeutics was reported to be:

โ‚น39.85 Billion
by Nasdaq info icon info icon
โ‚น39.85 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
โ‚น15.461 T 38,696.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น22.976 T 57,554.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Johnson & Johnson
JNJ
โ‚น45.775 T 114,762.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚น94.07 B 136.06%๐Ÿ‡บ๐Ÿ‡ธ USA